RegenMedEd roundtable with FDA’s office of therapeutic products (OTP) (from Catapult's regulatory round-up for December 2024)

The FDA’s Center for Biologics Evaluation and Research (CBER), OTP will be hosting a webinar on 30th January 2025 which is part of an educational series, RegenMedEd. This series aims to provide foundational information about regenerative medicine therapies, such as cell and gene therapy products, and explore opportunities for patients, care partners, and advocates to engage with FDA to help advance product development of OTP-regulated products. Leaders from across OTP will provide informatio...